✅ 8 criteria passed
❌ 3 criteria to solve
Boost pfizermedicalinformation.com's SEO with Kontactr's Guest Posting.
Secure high-authority, do-follow backlinks from our trusted site—DA44 domain authority and PA55 homepage and blog pages.
Perfect for webmasters seeking higher search rankings and increased organic traffic.
Simple, quick, and effective.
opens a new window
Information for Healthcare Professionals | Pfizer Medical Information...
https://pfizermedicalinformation.com
Medical site for healthcare professionals to search for scientific info on Pfizer medications. Find the package insert, new information, resources, and channels to c...
https://pfizermedicalinformation.com
Information for Healthcare Professionals | Pfizer Medical Information...
Medical site for healthcare professionals to search for scientific info on Pfizer medications. Find the package insert, new inform...
Great, a redirect is in place to redirect traffic from your non-preferred domain. All versions of your page point to the same URL.
| Attribute | Value |
| ⓘ viewport | width=device-width |
ⓘ The results of our semantic analysis are shown below using the website's language.
They are the main concepts covered by pfizermedicalinformation.com.
Each concept has a confidence score. The higher it is, the more important the topic is relative to the page.
| Topics | |
Pfizer Confidence: 87%
|
|
Package insert Confidence: 76%
|
|
Pharmaceutical drug Confidence: 71%
|
|
Medicine Confidence: 66%
|
|
Health professional Confidence: 65%
|
✅ pfizermedicalinformation.com website speed is normal. Page speed is important for visitors and search engines.
Get insights to improve your page loading time.
ⓘ This website is ranked #464.802 by Alexa.
This rank is traffic based. The lower the rank is, the better the domain is ranked.
| Country | Rank |
United States of America |
#250.368 |
Mobile Rendering
This website seems to be optimized for Mobile Visitors.
Phone
Tablet
A good text to HTML ratio is anywhere from 25 to 70%.
This percentage refers to the visible text ratio, as opposed to HTML elements, image tags and other non-visible information.
Great, we found headings on this page.
| Top level heading |
| Medical ınformation |
| 2nd level heading |
| Search medical ınformation* |
| Recent announcements |
| You are leaving pfizermedicalınformation.com |
We found 11 images on this website.
1
ALT attributes are missing on your image tags.
| Image | Image URL | Occurrences |
| https://pfizer.122.2o7.net/b/ss/pfizerusmiprod,pfizerusmigloabalprod/1/H.25.2--NS/0/5865162 | 1 |
Alternative text allows you to add a description to an image.
Google rely on alternative text attributes to determine relevance to a search query. Alternative text also makes an image more likely to appear in a Google image search.
It looks like you're missing alternative text for 1 images on pfizermedicalinformation.com. Check your website to make sure it's specified for each image on the page.
| Anchor | Type | URL |
![]() |
image | /en-us |
| Medical Information | text | /en-us |
| Log out | text | /en-us/user/logout |
| click here | text | /en-us/patient |
![]() |
image | /en-us |
| Search | text | /en-us/search |
| Prescribing Information | text | /en-us/prescribing-information |
| Information for Patients | text | /en-us/patient |
| Search | text | /en-us/search/patient |
| Medical Inquiries | text | /en-us/medical-request |
| Therapeutic Areas | text | /en-us/therapeutic-areas |
| Resources Library | text | /en-us/resources |
| Contact Us | text | /en-us/contact-us |
| Resources and Contact Us | text | /en-us/patient/contact-us |
| About Us | text | /en-us/about-us |
![]() |
image | medical-request |
| Send us a Medical Question | text | medical-request |
| Partner4Better (P4B) Launches! | text | /en-us/announcement/partner4better-p4b-launches |
| Pfizer Inc. Issues A Voluntary Nationwide Recall For 2 Lots of RELPAX® (... | text | /en-us/announcement/pfizer-inc-issues-voluntary-nationwide-recall-2-lots-relpaxr-eletriptan-hydrobro... |
| Pfizer Receives U.S. FDA Approval for Its Oncology Biosimilar, ZIRABEV™ (... | text | /en-us/announcement/pfizer-receives-us-fda-approval-its-oncology-biosimilar-zirabevtm-bevacizumab-bv... |
![]() |
image | resources |
| Professional Resources | text | resources |
![]() |
image | resources |
| Clinical Trials | text | resources |
![]() |
image | resources |
| Patient Assistance | text | resources |
| Announcements | text | /en-us/announcements |
| Terms of use | text | /en-us/terms-use |
| Terms of Use | text | /en-us/patient/terms-use |
| Website Demonstration | text | /en-us/demo |
| Site Map | text | /en-us/sitemap |
| I am a US Patient or Caregiver | text | /en-us/helpful-links-consumers |
| Anchor | Type | URL |
![]() |
image | https://chat.druginfo.com/i3root/pfizer%20us/pfizer_us_welcome.html |
| Chat Live Online | text | https://chat.druginfo.com/i3root/pfizer%20us/pfizer_us_welcome.html |
| Privacy Policy | text | http://www.pfizer.com/general/privacy.jsp |
| Pfizer.com | text | http://pfizer.com |
| Pfizerpro.com | text | http://pfizerpro.com |
| Feedback | text | https://pfizermi.az1.qualtrics.com/jfe/form/sv_9h7sag44a7tf2yz |
| Feedback | text | https://pfizermi.az1.qualtrics.com/jfe/form/sv_0cfvctnb0svuhvh |
| image | http://www.omniture.com | |
| click here | text | http://www.pfizer.com/products/medical-information/medical-information |
| ⓘ Domain Registrar | MARKMONITOR, INC. |
| ⓘ Registration Date | 07/19/2005 20 years, 6 months, 18 days ago |
| ⓘ Last Modified | 12/18/2018 7 years, 1 month, 16 days ago |
| ⓘ Expiration Date | 07/19/2020 Expired |
| Host | IP Address | Country |
| ns3.p15.dynect.net | 208.78.71.15 | United States |
| ns4.p15.dynect.net | 204.13.251.15 | United States |
| ns2.p15.dynect.net | 204.13.250.15 | United States |
| ns1.p15.dynect.net | 208.78.70.15 | United States |
| Domain |
United States of America (42.6%)
ⓘ Responsive website, mobile-friendly.
SOCIAL MEDIA PRESENCE
It's a good start.
You should focus on obtaining more social shares to improve your overall SEO strategy. Check out these tips to build a better social media presence.